Oral cancer stem cells: Therapeutic implications and challenges

LA Shahoumi - Frontiers in Oral Health, 2021 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) is currently one of the 10 most common
malignancies worldwide, characterized by a biologically highly diverse group of tumors with …

Human endogenous retroviruses role in cancer cell stemness

C Matteucci, E Balestrieri, A Argaw-Denboba… - Seminars in cancer …, 2018 - Elsevier
Cancer incidence and mortality, metastasis, drug resistance and recurrence are still the
critical issues of oncological diseases. In this scenario, increasing scientific evidences …

Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications

M Marzagalli, M Raimondi, F Fontana… - Seminars in Cancer …, 2019 - Elsevier
Malignant melanoma is a tumor characterized by a very high level of heterogeneity,
responsible for its malignant behavior and ability to escape from standard therapies. In this …

Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons

A Gisina, Y Kim, K Yarygin, A Lupatov - International Journal of Molecular …, 2023 - mdpi.com
The CD133 cell membrane glycoprotein, also termed prominin-1, is expressed on some of
the tumor cells of both solid and blood malignancies. The CD133-positive tumor cells were …

Role of biomarkers in the integrated management of melanoma

PP Naik - Disease Markers, 2021 - Wiley Online Library
Melanoma, which is an aggressive skin cancer, is currently the fifth and seventh most
common cancer in men and women, respectively. The American Cancer Society reported …

Melanoma-derived exosomes induce PD-1 overexpression and tumor progression via mesenchymal stem cell oncogenic reprogramming

E Gyukity-Sebestyén, M Harmati, G Dobra… - Frontiers in …, 2019 - frontiersin.org
Recently, it has been described that programmed cell death protein 1 (PD-1) overexpressing
melanoma cells are highly aggressive. However, until now it has not been defined which …

CD133-dependent activation of phosphoinositide 3-kinase/AKT/mammalian target of rapamycin signaling in melanoma progression and drug resistance

N Kharouf, TW Flanagan, AA Alamodi, Y Al Hmada… - Cells, 2024 - mdpi.com
Melanoma frequently harbors genetic alterations in key molecules leading to the aberrant
activation of PI3K and its downstream pathways. Although the role of PI3K/AKT/mTOR in …

Lipid storage and autophagy in melanoma cancer cells

C Giampietri, S Petrungaro, M Cordella… - International journal of …, 2017 - mdpi.com
Cancer stem cells (CSC) represent a key cellular subpopulation controlling biological
features such as cancer progression in all cancer types. By using melanospheres …

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Y Al Hmada, RT Brodell, N Kharouf, TW Flanagan… - Cancers, 2024 - mdpi.com
Simple Summary Melanoma is the third most common type of skin cancer. Melanoma is a
heterogeneous tumor, composed of genetically divergent subpopulations. These …

Biomarkers in malignant melanoma: recent trends and critical perspective

B Belter, C Haase-Kohn, J Pietzsch - Exon Publications, 2017 - exonpublications.com
The worldwide incidence of malignant melanoma is steadily increasing, suggesting a
probable melanoma “epidemic.” From a clinical point of view, malignant melanoma still is an …